An interventional study of Transpersonal Supportive Coaching and Standard Support in HIV, sponsored by Muh. Yusuf Tahir. Status unknown at 1 site in Indonesia. Open to participants aged 17 Years to 45 Years. Per ClinicalTrials.gov, last updated 2022-12-28.
Sponsored by Muh. Yusuf Tahir · Not applicable, Interventional, and Supportive care
Introduction:
Coaching is a process of self-exploration, thoughts, and feelings followed by actions within the coachee, through the relationship between the coachee and the coach. This process will help discover potencies in oneself as part of psychological and emotional support.
Objective:
To investigate the effectiveness of Transpersonal Supportive Coaching on Serotonin Levels and Quality of Life PLWHA.
Method:
This research was conducted using an intervention mixed-methods design which is the integration of quantitative and qualitative approaches to study designs, data collections, and analyses.
Alternative hypothesis:
Sampling technique: Purposive sampling
Sample Size :
The estimation of sample size was calculated using the Slovin formula:
n = N / (1 + (N x e²))
n = sample N = population e = margin error (0.05)
n = 100/(1+100 x 0.0025) = 80
The sample will be divided into 3 groups (each group = 26.67 or 27).
Detailed Intervention:
Statistical analysis:
Quantitative analysis:
This is the only study on the registry with Muh. Yusuf Tahir as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drop Out (DO) criteria:
PLWHA is given coaching using standard operating procedures (SOP) for Transpersonal Supportive Coaching to encourage or guide patients in obtaining support. The necessary tool is a representative room for two people with two chairs.
Other: Transpersonal Supportive Coaching
PLWHA is given standard support provided by peer support foundations
Other: Standard Support
PLWHA is not given any kind of support
Coaching is given for four months (two times a month) with a 45-minute duration per coaching by a professional coach
Standard support is given for four months using a support system provided by Peer Support Foundation
The change in blood serotonin level
Serotonin (5-hydroxytryptamine, 5-HT) is one of the main neurotransmitters in the human brain that could be affected by psychotherapy (i.e., change the serotonin levels). Total serotonin levels in the blood are measured using the Enzyme-linked Immunoassay (ELISA) method with a standard curve range of 70 ng/L-270 ng/L. The change in serotonin level (i.e., mean score) before and after intervention will be statistically assessed.
Time frame: The baseline level of serotonin in blood is measured on the first day before intervention (pre-intervention) and then compared after 4-months of intervention (post-intervention)
The change in Quality of life (QoL) of PLWHA
Quality of life is defined as individuals' perception of their position in life in the context of the culture and value system in which they live and in relation to their goals, expectations, standards, and concern which measure using the modified World Health Organization's Quality of Life Questionnaire (WHOQOL-BREF) questionnaire in Indonesian version to measure the QoL patients with HIV/AIDS. it is a 31-item instrument consisting of six domains: physical health (4 items), psychological/emotional well-being (5 items), functional/independence (4 items), social (4 items), environmental (8 items) and spiritual satisfaction (4 items). Further, it also contains overall quality of life and general health perception (2 items). Each item's scores range between 1 (very bad) and 5 (very good). A total score and total of each domain at baseline and after the intervention will be statistically assessed. A positive score change indicates good QoL, while a negative indicates worse QoL.
Time frame: The baseline score of total and each domain of Quality of Life on PLWHA is measured on the first day before intervention (pre-intervention) and then compared after 4-months of intervention (post-intervention).
This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.